Clinical Trials Logo

Clinical Trial Summary

Unilateral posterior canal benign paroxysmal positional vertigo (BPPV) cases will be randomized to treat with single or multiple cycles of canalith repositioning procedure.The treatment outcomes will be assessed at 7th and 28th days.


Clinical Trial Description

Patients present with brief episodes of vertigo will be evaluated by Dix-Hallpike test. Cases with positive Dix-Hallpike test, unilateral, posterior canal, will be randomized with block of four. Either single or multiple cycles of canalith repositioning procedure will be performed. Four treatment outcomes will be blindly assessed at 7 and 28 days. ;


Study Design


Related Conditions & MeSH terms

  • Benign Paroxysmal Positional Vertigo
  • Benign Paroxysmal Positional Vertigo (BPPV)
  • Dizziness
  • Vertigo

NCT number NCT02701218
Study type Interventional
Source Chiang Mai University
Contact Suwicha I Kaewsiri, MD
Phone 66-816802036
Email suwicha.kaewsiri@cmu.ac.th
Status Recruiting
Phase N/A
Start date February 2016
Completion date December 2019

See also
  Status Clinical Trial Phase
Recruiting NCT01822002 - Treatment of Posterior Canal Type of Benign Paroxysmal Positional Vertigo N/A
Completed NCT04849182 - Vertistop® D and Vertistop® L in Preventing Recurrence of High-recurrence BPPV N/A
Recruiting NCT04935970 - Metabolic Disorders and Vertigo
Recruiting NCT05984901 - The CAVA Multicentre Dizziness Trial N/A